Product Information
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB is a generic product labeled by Strides Pharma Inc., priced at $6.0567 per EA under NDC 64380020001. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Jun 1, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB
amlodipine besylate valsartan hydrochlorothiazideStrength
10; 25; 160 mg/1; mg/1; mg/1
Manufacturer
Strides Pharma Inc.NDC
64380020001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA201087FDA Approved
6/1/2015
TE Code
AB
On Market Since
6/27/2022
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 17.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.0567 per EA |
|---|---|
| All-time high | $8.3788 (Oct 15, 2025) |
| All-time low | $5.9684 (Jul 22, 2026) |
| 52-week high | $8.3788 |
| 52-week low | $5.9684 |
| Median price | $7.3220 |
| Average price | $7.4099 |
| Largest weekly change | -6.8% (May 20, 2026) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amlodipine besylate valsartan hydrochlorothiazide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB, manufactured by Strides Pharma Inc., is $6.0567 per EA (NDC 64380020001), effective Aug 19, 2026.
How has the price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB has declined 17.2%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB?
Since Apr 17, 2024, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB has ranged from a low of $5.9684 (Jul 22, 2026) to a high of $8.3788 (Oct 15, 2025), with a median of $7.3220 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB?
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB (NDC 64380020001) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.